Thursday, December 12, 2024 1:24:37 PM
It happens with these biomed stocks after a press release
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent CADL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:08:06 PM
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/02/2026 08:05:00 PM
- Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors • GlobeNewswire Inc. • 03/17/2026 12:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/12/2026 12:58:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 12:17:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:10:26 PM
- Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/12/2026 12:05:00 PM
- Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting • GlobeNewswire Inc. • 03/09/2026 12:05:00 PM
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/02/2026 09:05:00 PM
- Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 01:00:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/20/2026 09:16:14 PM
- Candel Therapeutics Announces Pricing of Public Offering • GlobeNewswire Inc. • 02/20/2026 02:40:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/19/2026 09:31:42 PM
- Candel Therapeutics Announces Proposed $100 Million Public Offering • GlobeNewswire Inc. • 02/19/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:03:06 PM
- Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer • GlobeNewswire Inc. • 02/19/2026 09:01:00 PM
- Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit • GlobeNewswire Inc. • 02/11/2026 01:05:00 PM
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:04:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:02:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:01:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:00:12 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/21/2026 05:30:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 01:30:52 PM
